MedTrace Logo

Observational Study of Azilsartan/Chlorthalidone and Irbesartan/Hydrochlorothiazide in Hypertension and Obesity.

NCT03006796 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 94

Last updated 2020-10-19

No results posted yet for this study

Summary

This is an observational prospective study of azilsartan medoxomil / chlorthalidone compared with irbesartan / hydrochlorothiazide in routine therapy of patients with arterial hypertension and obesity.

Conditions

  • Arterial Hypertension

Sponsors & Collaborators

  • Russian Heart Failure Society

    lead OTHER

Principal Investigators

  • Yury A Vasyuk, MD · Russian HFS

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-16
Primary Completion
2020-02-29
Completion
2020-03-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03006796 on ClinicalTrials.gov